Skip to content
10-Q

Quarterly Report

Galera Therapeutics, Inc. GRTX

0000950170-25-071956

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 75.46M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $6.69M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $8.29M
Current Liabilities Q1 2025 · Mar 31, 2025 $975K
Current Liabilities Q1 2025 · Dec 31, 2024 $1.67M
Total Liabilities Q1 2025 · Mar 31, 2025 $152.02M
Total Liabilities Q1 2025 · Dec 31, 2024 $153.77M
Current Assets Q1 2025 · Mar 31, 2025 $7.56M
Current Assets Q1 2025 · Dec 31, 2024 $10M
Total Assets Q1 2025 · Mar 31, 2025 $7.66M
Total Assets Q1 2025 · Dec 31, 2024 $10.1M
Shares Diluted Q1 2025 · Mar 31, 2024 54.39M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.79M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$134.69M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$131.19M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.08
Eps Basic Q1 2025 · Mar 31, 2024 −$0.08
Sga Expense Q1 2025 · Mar 31, 2024 $3.09M
Rd Expense Q1 2025 · Mar 31, 2024 $1.49M
Net Income Q1 2025 · Mar 31, 2024 −$4.38M
Operating Income Q1 2025 · Mar 31, 2024 −$4.58M